Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
77 Cards in this Set
- Front
- Back
- 3rd side (hint)
What are the three major classes of receptor signals?
|
1) phosphorylation/ dephosphorylatin… 2) GTP/GDP exchange… 3) Acetylation/deacetylation (Post translational modification not a receptor signal)
|
|
|
Illustrate the phosphorylation pathway
|
Dephosphorylated substrate (inactive) --> Protein kinase w/ ATP --> (ADP byproduct) + Phosphorylated substrate (active) --> [interaction with effectors-AND/OR- Protein phosphatase] --> (Pi byproduct) + Dephosphorylated substate (inactive)
|
None
|
|
Name the 6 signaling pathways.
|
1) nuclear hormone receptors… 2) ligand-gated ion channels… 3) G protein coupled receptors (with second messenger c-AMP)… 4) Receptor protein tryosine kinase (RAS and MAP Kinase)… 5) cytokines receptor and non-receptor tyrosine kinase… 6) proteolysis regulated signals
|
None
|
|
Which of the signaling systems utilizes different domains with various functions as well as a basic plan?
|
Nuclear hormone receptors
|
|
|
Which cancers would be good candidates for nuclear hormone receptors?
|
breast, prostate, APL
|
|
|
Why are multiple waves of signaling seen in NHRs?
|
NHR's secondary response would be downstream gene activation
|
|
|
Do NHRs cause phosphorylation?
|
Not directly… indirectly through other activated gene products
|
|
|
What are the 4 classes of stimulating/inhibiting molecule that affect NHR activity?
|
antagonists, agonists, inverse agonists, partial agonists
|
None
|
|
Do Antagonists change the ratio (equilibrium)?
|
no
|
|
|
What are 3 ways to prevent hormone production?
|
1) remove organ… 2) chemical castration… 3) prevent biosynthesis
|
|
|
What is an LHRH agonist? What is its mechanism of action? What cancer is it used to treat?
|
It a method of chemical casatration to prevent the synthesis of hormones… it does it by desensitizing the system and thus shuts the system down… it used in prostate cancer
|
None
|
|
What is an aromatase inhibitor? What is its mechanism of action? What type of cancer is it used to treat?
|
It inhibits aromatase, which is an enzyme needed for estrogen and progesterone synthesis (found in fat cells.. Thus obesity is associagted with breast cancer)
Estrogen receptor positive |
None
|
|
which three molecules used in preventing hormone binding to its receptors?
|
Receptor antagonists, partial agonists, anti-androgen,
|
None
|
|
What type of hormone interrupting drug is Tamoxifen… and what is it used for?
|
Receptor antagonist/partial
agonist… breast cancer... estrogen receptor positive |
None
|
|
What type of hormone interrupting drug is Flutamide… and what is it used for?
|
pure antiadrogen/receptor antagonist… prostate
|
|
|
What is the role of 5-HT3 in cancer and how does it gain its selectivity?
|
5-HT3 is a serotonin ligand gated ion channel, which is related to nausea and vomiting… this receptor is unique when compared to other Serotonin receptors (Na and K)
|
|
|
Which receptor is a seven transmembrane protein? What is another name for this type of receptor?
|
G-protein coupled receptor… heptahelical receptor
|
|
|
What types of extracellular signals activate G-Protein coupled receptors?
|
Many: Sensory (light, tastes), ions, small peptides, proteins, and enzymes
|
None
|
|
Which cell signalling pathway accounts for 70% of all drug sales (including illegal) and 50% of legal drugs
|
GPCR
|
None
|
|
Give the pathway for G-proteins.
|
G protein-GDP + GEF + GTP -(loss of GDP)-> G-protein-GTP -> [interaction with effectors -> leads to biological functions] --> G-protein-GTP +GAP -(loss of Pi)-> G-protein-GDP
|
None
|
|
What are the components of a GPCR?
|
Receptor, ß, ∂, (ligand that binds the receptor) and GTP or GDP
|
|
|
What is the GEF in GPCR?
|
the receptor
|
|
|
What binds the GTP in GPCR?
|
the Alpha subunit
|
None
|
|
Give the cAMP pathway in a GPCR.
|
G∂ --> Adenylyl cyclase + ATP --> 4-each cAMP + inactive PKA --> active PKA (catalytic subunits) enter nucleus and phosphorylate CREB (transcription factor)
|
|
|
What causes Kaposi's sarcoma? ... Which signal transduction pathway (receptor) is implicated in this disease? What is the direct result of this pathway somatick mutation?
|
Human herpesvirus 8 (HHV8), which contains GPCR with constitutive activity --> leads to angiogenosis
|
None
|
|
What clinical manifestations would arise from an HHV8 infected AIDS patient?
|
stimulation of angiogenosis --> neoplasms with highly vascular multiple cell types in the skin , lungs and the GI tract (including mouth)
|
None
|
|
In Kaposi's sarcoma, what two mechanisms is effected and as a result, what is released from the cells?
|
HHV8 constitutively activates the G-protein coupled receptor signaling pathway --> which leads to secretion of VEGF
|
None
|
|
Match the following: APL and CML… fusion of Bcr-to-ABL, PML-to-RAR… which requires a Flt3 mutation.
|
APL: PML-RAR (requires Flt3 mutation)… CML: Bcr-ABL
|
None
|
|
Name the receptor type: domains have a specific function
|
NHR
|
|
|
Name the receptor type: flt3
|
receptor protein tyrosine kinase
|
None
|
|
Name the receptor type: causes APL
|
RAR:nuclear hormone receptor… and Flt3: receptor tyrosine kinase
|
|
|
Name the receptor type: implicated in CML
|
non-tyrosine kinase: Bcr-ABL
|
None
|
|
Name the receptor type:Rx is retinoic acid
|
PML-RAR: NHR
|
|
|
Name the receptor type: Gleevec is used as a Rx
|
ABL- non receptor kinase: Bcr-ABL philidelphia chromosome
|
|
|
Name the receptor type: blocked with agonists, antagonists, inverse agonist
|
NHR
|
|
|
Name the receptor type:5-HT3
|
ligand gated ion channel: serotonin
|
|
|
Name the receptor type: 7 transmembrane receptor
|
G-protein
|
|
|
Name the receptor type: associated with scaffolds and signaling complexes
|
receptor protein tyrosine kinase
|
|
|
Name the receptor type: wide variety of activating signals
|
g-protein
|
|
|
Name the receptor type: activated by dimerization
|
receptor protein tyrosine kinase… cytokine receptors, non-tyrosine kinase (src, Jak-STAT), ErbB2 (RTK example of heterodimers)
|
None
|
|
Name the receptor type: receptor acts as GEF
|
g-protein coupled receptor
|
|
|
Name the receptor type: associated with ErbB2
|
receptor protein tyrosine kinase
|
|
|
How does ErbB2 activate
|
dimerization
|
|
|
What is the mechanism of action for Herceptin (ErbB2/Her2/neu?
|
mAb-Her2 (for receptor)... down-regulation or cytoxic mediated
|
None
|
|
What is the mechanism for Gleevec?
|
blocks the binding of ATP to Bcr-ABL
|
|
|
Name the receptor type: capable of autophosphorylation
|
receptor protein tyrosine kinase
|
|
|
Name the receptor type: utilizes the RAS MAP kinase pathway
|
tyrosine and non-tyrosine kinase pathways, including cytokine receptors
|
|
|
Name the receptor type: associated with proteolysis
|
Notch signaling
|
|
|
Name the receptor type: Jak-STAT and Src Kinase
|
non-tyrosine kinase
|
None
|
|
Name the receptor type: implicated in Acute lymphocytic leukemia (ALL)
|
Non-receptor kinase: Bcr-ABL philidelphia chromosome
|
None
|
|
What is the role of ABL in CML?
|
influences cell cycle vs. apoptosis
|
|
|
Which (ABL or Bcr) expresses src homology, DNA binding, and acting binding domains?
|
ABL
|
|
|
Which (ABL or Bcr) expresses kinase and dimerization domains (and GEF/GAP)?
|
Bcr
|
|
|
What is Ki-1 lymphoma caused by?
|
fusion of NPM and ALK to produce a constitutively active protein
|
|
|
What type of receptor is Ki-1 lymphoma?
|
receptor protein tyrosine kinase
|
None
|
|
What is Ki-1 lymphoma (the fusion of proteins NPM and Alk) an example of?
|
bad scaffolding… thus it has abnormal distribution
|
None
|
|
Match the functions of NPM and ALK: Oligodimerizes, kinase, found in the nucleus
|
NPM: oligodimerizes + found in the nucleus… ALK: kinase
|
|
|
Name the receptor type: associated with erbB2 and Ki-1 lymphoma (NPM-ALK)
|
receptor protein tyrosine kinase
|
|
|
Name the receptor type and name: EGFR, heterodimerizing, no known ligand,
|
RTK, erbB2/HER2/neu
|
|
|
Who are the candidates for Herceptin? What is the strategy?
|
erbB2/HER2/neu… anti-mAB (which binds the receptor)
|
None
|
|
What are the 5 strategies for blocking RTKs?
|
1) bind ligand w/Ab… 2) soluble receptor… 3) block tyrosine kinase itself… 4) stimulate degradation of kinase… 5) block transcription factors
|
|
|
what are the 2 proposed mechanisms of Herceptin?
|
1) down regulates Her2/neu... 2) mAB works with cytoxic T-cells...
|
None
|
|
What are the side effects of herceptin?
|
cardiotoxicity
|
|
|
Which chromosomes are Bcr and ABL found on?
|
bcr=22… abl=9
|
|
|
Which disease presents with high WBC, splengomegaly, fatigue and weight loss?
|
CML… bcr-ABL
|
|
|
Which translocation mutation leads to adhesion, mitogenesis, inhibition of apoptosis
|
Bcr-ABL: Ph chr...
|
AIM stripped toothpaste
|
|
What are possible causes of resistance to STI571? (Gleevec) Which is most likely?
|
increased BCR-ABL, pumpls, point mutations so that it no longer fits in cleft… point mutation in pocket
|
|
|
T/F: KSHV GPCR activate more than one signaling pathway
|
True
|
|
|
Name the 6 stages of angiogenesis
|
1. Endothelial cell activation
2. Basement membrane degradation 3. Endothelial cell imigration 4. Invasion of the ECM 5. Endothelial cell proliferation 6. New capillary tube formation |
|
|
What 4 things can trigger angiogenesis?
|
1. tumor hypoxia
2. oncogenes 3. cytokines 4. cell growth factors |
|
|
Give 5 reasons why angiogenesis is a good target for chemotherapy.
|
1. Endothelial cells are not malignant
2. Tumors require blood supply 3. Blood vessel density = tumor aggressiveness 4. Angiogenesis inhibition causes tumor regression in mice 5. Many standard chemo-drugs have anti-angiogenic properties |
|
|
What are the two forms of Ab?
|
Cell surface Ab and soluble target Ab
|
|
|
Give 3 mechanisms used in antibody-based therapy.
|
1. Ab-Toxin
2. Ab --> activates immune system 3. Alter cell signalling: - remove growth factor for circulation - Clearing receptor from the cell |
|
|
What type of toxicity is seen with Avastin? What is the mechanism of action for AV (BV)?
|
1. hypertention (nominal GI perforation)
2. Human mAb directed at VEGF |
|
|
What is Avastin's (BV/AV) mechanism of action?
|
Anti-VEGF mAb
|
|
|
Name 4 anti-Angiogenic therapies in clinical trials.
|
1. Endogenously occuring inhibitors: a) Agiostatin... b) Endostatin
2. Inhibition of pro-angiogenic factors: VEGF (Avastin = anti-VEGF mAB) 3. IL-12: upregulates antagonists of KSHV-GPCR. 4. Thalidomide |
|
|
What is the mechanism of pathology behing ErbB2/HER2/neu tumor models?
|
Two hits:
1. Gene amplification --> protein overexpression 2. Transformed cells only occur when overexpression of ErbB2/HER2/neu is accompanied by other EGFR overexpression |
|